September 9, 2014

BioBridge Global has selected Michael Moloney to be the chief operating officer for GenCure, BioBridge Global’s regenerative medicine arm. GenCure encompasses operations for tissue procurement and processing, cellular therapy and cord blood. BioBridge Global CEO Linda Myers made the announcement today.

Moloney is long established in the biomedical field, including serving at high-level positions at Duke University Medical Center and San Antonio’s BioNumerik Pharmaceuticals, United Allergy Labs and most recently as COO of OncoVista Innovative Therapies, which conducts research and development in the cancer therapeutic arena.